A single report by Milde-Langosch and colleagues [38] reported that approximately 25–30% of cervical carcinomas and severe dysplasias exhibited over-expression of c-Myc, but none of the evaluated endometrial lesions that included adenomyosis specimens exhibited c-Myc over-expression. The gene discussed is MYC; the disease is cervical carcinoma.